Double-blind comparison of alclofenac and phenylbutazone in the short-term treatment of rheumatoid arthritis.
D000284:Administration, Oral; D000498:Allyl Compounds / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D000886:Anthropometry; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000145:classification / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D006801:Humans; D007596:Joints / Q000187:drug effects; D009043:Motor Activity / Q000187:drug effects; D009088:Mucoproteins / Q000097:blood; D010146:Pain / Q000188:drug therapy; D010647:Phenyl Ethers / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D010648:Phenylacetates / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D010653:Phenylbutazone / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D013997:Time Factors; D014443:Tyrosine / Q000097:blood; D014527:Uric Acid / Q000097:blood
D000498:Allyl Compounds; D000893:Anti-Inflammatory Agents; D009088:Mucoproteins; D010647:Phenyl Ethers; D010648:Phenylacetates; D014527:Uric Acid; D014443:Tyrosine; D010653:Phenylbutazone